Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice

Radiation Research

Volumn 155, Issue 1, 2001, Pages 26-31

  Sun, L Q ^a   Buchegger, F ^a   Coucke, P A ^a   Mirimanoff, R O ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; NICOTINAMIDE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; CONTROLLED STUDY; DESQUAMATION; DRUG EFFECT; FEMALE; GLIOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; SKIN INJURY; XENOGRAFT;

MUS MUSCULUS;

EID: 0035146565     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0026:FICWCB]2.0.CO;2     Document Type: Article

References (38)

1. Brain tumors
2. Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases)
3. Radiosensitization with normobaric oxygen and carbogen
4. 2) and radiosensitivity
5. Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation
6. Human tumor blood flow is enhanced by nicotinamide and carbogen breathing
7. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation
8. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumors
9. Tumor radiosensitization by nicotinamide: A result of improved perfusion and oxygenation
10. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor
11. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII routine tumors and normal tissues
12. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments
13. Carbogen and nicotinamide as radiosensitizers in a routine mammary carcinoma using conventional and accelerated radiotherapy
14. Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens?
15. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing
16. Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas
17. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: A new modality treatment
18. Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma
19. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas
20. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: Report of European organization for research and treatment of cancer trial 22933
21. 2 distribution and bioreductire enzymes in human malignant brain tumors
22. Intratumoral oxygen pressure in malignant brain tumors
23. The effects of combined nicotinamide and carbogen treatments in human turnout xenografts: Oxygenation and turnout control studies
24. Analysis of the p 53 gene and its expression in human glioblastoma cells
25. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted turnout in mice
26. Nicotinamide pharmacokinetics in humans and mice: A comparative assessment and the implications for radiotherapy
27. Nicotinamide as a radiosensitizer in tumors and normal tissues: The importance of drug dose and timing
28. The effects of divided doses of 15 MeV electrons on the skin response of mice
29. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report
30. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample
31. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: Therapeutic gain comparisons for fractionated x-ray schedules
32. Vascular and perfusion of human gliomas xenografted in the athymic nude mice
33. Combination of fractionated irradiation with nicotinamide and carbogen in RIH-tumours of the rat and its pulmonary metastases
34. 99mTc-HMPAO SPECT study
35. ARCON: Accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: A phase I/II study by the EORTC
36. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer
37. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide
38. Tolerance to nicotinamide and carbogen with radiation therapy for glioblastoma